1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 660 Developing generalizable deep learning models for tumor segmentation in pathology images to enable the identification of predictive biomarkers for immunotherapies. (9th November 2020) Authors: Ba, Qinle; Yang, Peng; Yearley, Jennifer Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A396 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 660 Developing generalizable deep learning models for tumor segmentation in pathology images to enable the identification of predictive biomarkers for immunotherapies. (9th November 2020) Authors: Ba, Qinle; Yang, Peng; Yearley, Jennifer Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A697 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CTIM-32. PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS. (9th November 2020) Authors: Reardon, David; Molinaro, Annette; Peters, Katherine; Clarke, Jennifer; Jordan, Justin; de Groot, John; Nghiemphu, Phioanh; Kaley, Thomas; Colman, Howard; McCluskey, Christine; Smith, Timothy; Cote, David; Severgnini, Mariano; Yearley, Jennifer; Zhao, Qing; Blumenschein, Wendy; Duda, Gabriel; Muz... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. NCOG-44. NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA. (9th November 2020) Authors: Nayak, Lakshmi; Molinaro, Annette; Peters, Katherine; Clarke, Jennifer; Jordan, Justin; de Groot, John; Nghiemphu, Phioanh; Kaley, Thomas; Colman, Howard; McCluskey, Christine; Gaffey, Sarah; Smith, Timothy; Cote, David; Severgnini, Mariano; Yearley, Jennifer; Zhao, Qing; Blumenschein, Wendy; Dud... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patterns of PD‐1, PD‐L1, and PD‐L2 expression in pediatric solid tumors. Issue 11 (10th May 2017) Authors: Pinto, Navin; Park, Julie R.; Murphy, Erin; Yearley, Jennifer; McClanahan, Terri; Annamalai, Lakshmanan; Hawkins, Douglas S.; Rudzinski, Erin R. Journal: Pediatric blood & cancer Issue: Volume 64:Issue 11(2017) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Pembrolizumab in mycosis fungoides and Sézary syndrome: Updated results of the CITN multicenter Phase 2 study. (September 2018) Authors: Khodadoust, Michael S.; Rook, Alain H.; Porcu, Pierluigi; Foss, Francine; Moskowitz, Alison; Shustov, Andrei R.; Shanbhag, Satish; Sokol, Lubomir; Fling, Steven P.; Li, Shufeng; Fong, Sophia; Kim, Jinah; Yang, Yi; Yearley, Jennifer; Subrahmanyam, Priyanka; Maecker, Holden; Horwitz, Steven M.; Sha... Journal: European journal of cancer Issue: Volume 101(2018)Supplement 1 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Relationship between immune gene signatures and clinical response to PD-1 blockade with pembrolizumab (MK-3475) in patients with advanced solid tumors. (4th November 2015) Authors: Ayers, Mark; Lunceford, Jared; Nebozhyn, Michael; Murphy, Erin; Loboda, Andrey; Albright, Andrew; Cheng, Jonathan; Kang, S Peter; Ebbinghaus, Scot; Yearley, Jennifer; Shankaran, Veena; Seiwert, Tanguy; Ribas, Antoni; McClanahan, Terri Journal: Journal for immunotherapy of cancer Issue: Volume 3(2015)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗